Clinical requirements for drug therapy in women with iron deficiencies

Abstract

Iron deficiency anemia (IDA) is characterized by decreased iron levels in the serum, bone marrow and storage pools (spleen, liver, subcutaneous vascular plexus and lungs). IDA is one of the most common pathological conditions in clinical practice, found in 1.8 billion people all over the world [2]. High anaemia incidence is a public health problem both in developed and poor countries [1].

Keywords

• железодефицитная анемия
• женщины
• беременные
• препараты железа
• iron deficiency anemia
• women
• pregnant women
• iron preparations